Pro12Ala sequence variant of the PPARG gene is associated with postprandial hypertriglyceridemia in non-E3/E3 patients with the metabolic syndrome.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Chemistry

• Publication date

  2006-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1373/CLINCHEM.2006.069690PMID 16916989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The apolipoprotein E genotype predicts postprandial hypertriglyceridemia in patients with the metabolic syndrome.

  2005cited by this paper
• Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes.

  2005cited by this paper
• Gene-gene interaction of PPARgamma and ApoE affects coronary heart disease risk.

  2003cited by this paper
• Gene–gene interaction of PPARγ and ApoE affects coronary heart disease risk

  2003cited by this paper
• Dyslipidemia of the metabolic syndrome

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator‐activated receptor (PPAR) γ2 gene in healthy individuals

  2002cited by this paper
• Polymorphisms in candidate obesity genes and their interaction with dietary intake of n-6 polyunsaturated fatty acids affect obesity risk in a sub-sample of the EPIC-Heidelberg cohort

  2002influential reference
• Conditional Disruption of the Peroxisome Proliferator-Activated Receptor γ Gene in Mice Results in Lowered Expression of ABCA1, ABCG1, and apoE in Macrophages and Reduced Cholesterol Efflux

  2002cited by this paper
• The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.

  2001cited by this paper
• A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.

  2001cited by this paper
• The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 Diabetes

  2000cited by this paper
• Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis.

  2000cited by this paper
• Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus

  2000cited by this paper
• Apolipoprotein E and atherosclerosis.

  2000cited by this paper
• Molecular recognition of fatty acids by peroxisome proliferator-activated receptors.

  2000cited by this paper
• The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.

  2000cited by this paper
• The PPARγ2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects

  1999cited by this paper
• Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-γ2 (PPAR-γ2): divergent modulating effects on body mass index in obese and lean Caucasian men

  1999cited by this paper
• Hydrogen peroxide improves the efficiency of a peripheral blood PCR assay for diagnosis of human brucellosis.

  1999cited by this paper
• Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women.

  1999influential reference
• A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

  1998cited by this paper
• Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations.

  1998cited by this paper
• Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men.

  1998influential reference
• Impaired Glucose Tolerance is Normalized by Treatment With the Thiazolidinedione Troglitazone

  1997cited by this paper
• 108 Regulation of lipoprotein metabolism by thiazolidine-diones occurs through a distinct, but complementary mechanism relative to fibrates

  1997cited by this paper
• Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor γ (hPPARγ) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPARγ2 Missense Mutation

  1997cited by this paper
• Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates.

  1997cited by this paper
• Hyperinsulinemia and Abdominal Obesity Affect the Expression of Hypertriglyceridemia in Heterozygous Familial Lipoprotein Lipase Deficiency

  1997cited by this paper
• Banting lecture 1988

  1997cited by this paper
• Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation.

  1997cited by this paper
• PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene.

  1996cited by this paper
• Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

  1993cited by this paper
• Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.

  1990cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• Clinical Chemistry

  1884cited by this paper

• G Allele of the rs1801282 Polymorphism in PPARγ Gene Confers an Increased Risk of Obesity and Hypercholesterolemia, While T Allele of the rs3856806 Polymorphism Displays a Protective Role Against Dyslipidemia: A Systematic Review and Meta-Analysis

  2022cites this paper
• Association of PPARγ gene expression with postprandial hypertriglyceridaemia and risk of type 2 diabetes mellitus

  2020cites this paper
• Quantile-dependent expressivity of postprandial lipemia

  2020cites this paper
• Pyrosequencing on Acryl-Modified Glass Chip

  2016cites this paper
• Peroxisome proliferator activated receptor gamma polymorphism Pro12Ala in polycystic ovary syndrome (PCOS) of South Indian Population

  2016cites this paper
• Novel Oxazolidinone-Based Peroxisome Proliferator Activated Receptor Agonists: Molecular Modeling, Synthesis, and Biological Evaluation.

  2015cites this paper
• Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.

  2014cites this paper
• Association of the variants in the PPARG gene and serum lipid levels: a meta-analysis of 74 studies

  2014cites this paper
• The impact of fish‐oil fatty acids on postprandial vascular reactivity (959.22)

  2014cites this paper
• The association of Pro 12 Ala polymorphism in the peroxisome proliferator-activated receptor-gamma 2 gene with the metabolic characteristics in Chinese women with polycystic ovary syndrome

  2013cites this paper
• Inference of Cross-Level Interaction between Genes and Contextual Factors in a Matched Case-Control Metabolic Syndrome Study: A Bayesian Approach

  2013cites this paper
• The association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene with the metabolic characteristics in Chinese women with polycystic ovary syndrome.

  2013cites this paper
• The Retinoic Acid Receptor‐Related Orphan Nuclear Receptor γ1 (RORγ1): A Novel Player Determinant of Insulin Sensitivity in Morbid Obesity

  2012cites this paper
• Effects of peroxisome proliferator activated receptor-gamma 2 gene Pro12Ala polymorphism on fasting blood lipids: a meta-analysis.

  2011cites this paper
• Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4

  2010influential citation
• Effect of apolipoprotein C3 and apolipoprotein A1 polymorphisms on postprandial response to a fat overload in metabolic syndrome patients.

  2010cites this paper
• The -1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial study.

  2009cites this paper
• Revisión N-3 fatty acids in glucose metabolism and insulin sensitivity

  2009cites this paper
• Single‐nucleotide polymorphism typing based on pyrosequencing chemistry and acryl‐modified glass chip

  2009cites this paper
• N-3 fatty acids in glucose metabolism and insulin sensitivity.

  2009cites this paper
• Single gene contributions: genetic variants of peroxisome proliferator-activated receptor (isoforms α, β/δ and γ) and mechanisms of dyslipidemias

  2008cites this paper
• Mapping of quantitative trait loci for cholesterol, LDL, HDL, and triglyceride serum concentrations in pigs.

  2008cites this paper
• Influence of genetic factors in the modulation of postprandial lipemia.

  2008cites this paper
• PPARgamma mRNA expression is reduced in peripheral blood mononuclear cells after fat overload in patients with metabolic syndrome.

  2008cites this paper
• PPARg mRNA Expression Is Reduced in Peripheral Blood Mononuclear Cells after Fat Overload inPatientswithMetabolicSyndrome

  2008cites this paper
• PPARγ mRNA Expression Is Reduced in Peripheral Blood Mononuclear Cells after Fat Overload in Patients with Metabolic Syndrome

  2008cites this paper
• Effects of a PPARG gene variant on obesity characteristics in Brazil.

  2007cites this paper